BioLife Solutions, Inc.

11/20/2025

We’re pleased to announce the soft launch of The Aby J. Mathew Center for Biopreservation Excellence (“The Center”) in Bothell, WA.

* The Center bridges an expertise gap in biopreservation by providing therapy developers with data, tools, and mentorship to safeguard cell and tissue viability and accelerate clinical translation.

* The Center is led by Dr. Alireza Abazari and applies deep cryobiology expertise with trusted bioproduction tools to specifically help cell and gene therapy and biopharma organizations design optimized, reproducible, and regulatory-ready cell processing methods.

* The Center is named in honor of Dr. Aby J Mathew and his instrumental role in developing BioLife’s foundational biopreservation media technologies, enabling BioLife’s commercial growth and market success, and his pioneering contributions to advancing the science and integration of biopreservation, especially within the novel clinical and commercial CGT field.

* Dr. Mathew has been working on biopreservation media technologies for over 30 years and has been a founding team member of BioLife Solutions for over 25 years.

Learn more about The Center: https://go.biolifesolutions.com/The-Center

11/20/2025

BioLife Solutions Unveils the Aby J. Mathew Center for Biopreservation Excellence

New conference and laboratory facility to showcase the company's product portfolio and serve as a research and training hub to advance biopreservation and cell processing innovation

Find out more in the Press Release:
https://investors.biolifesolutions.com/2025-11-20-BioLife-Solutions-Unveils-the-Aby-J-Mathew-Center-for-Biopreservation-Excellence

11/17/2025

BioLife Solutions to Participate in Upcoming Investor Conferences in November and December 2025

Read the press release for more details.

https://investors.biolifesolutions.com/2025-11-17-BioLife-Solutions-to-Participate-in-Upcoming-Investor-Conferences-in-November-and-December-2025

11/13/2025

Our NEW website and brand messaging launched exactly two weeks ago. If you haven’t taken a look yet, we urge you to check it out soon!

Key Features:

* Streamlined navigation
* Main website chatbot
* Simplified Resource Center page
* Revamped Investors microsite
* Enhanced Evidence Library with a “BioLife Librarian” chatbot

New website: www.biolifesolutions.com

Visit the updated Evidence Library directly to search scientific journals, abstracts, posters, and presentations that cite BioLife tools and solutions, authored by customers and our scientific bench: https://evidence.biolifesolutions.com/

11/11/2025

The Advanced Therapies Therapies Congress USA is one week away!

Stop by BioLife’s booth 517 to catch up with Steven Thompson, Andrew Sabatier, and Vicky Tran. As you plan your itinerary, make sure to save Robert Ben’s talk on controlling ice crystal growth in cell therapy development in the event app.

* Tuesday, November 18
* 2:15pm ET
* Location: Innovation Showcase - Track 2, Seminar Theatre

See you soon at the Pennsylvania Convention Center in the “city of firsts”!

If you haven’t registered yet, book your spot now: https://secure.terrapinn.com/V5/step1.aspx?E=10972&p=1

11/06/2025

BioLife Solutions Reports Third Quarter 2025 Financial Results

Cell Processing revenue of $25.4 million, up 33% over Q3 2024.

GAAP gross margin of 62% and non-GAAP adjusted gross margin of 64%.

Join the live webcast now at 4:30pm ET or listen to the recording later: https://event.choruscall.com/mediaframe/webcast.html?webcastid=f0SVKDGR

Press Release: https://investors.biolifesolutions.com/2025-11-06-BioLife-Solutions-Reports-Third-Quarter-2025-Financial-Results

Cell Processing revenue of $25.4 million, up 33% over Q3 2024 GAAP gross margin of 62% and non-GAAP adjusted gross margin of 64% GAAP net income of $0.6 million and non-GAAP adjusted EBITDA of...

11/05/2025

If you are attending the Informa Connect Life Sciences “Cell & Gene Therapy International Europe 2025” conference in Berlin, Germany on December 1-3, come find us.

Steven Thompson, Andreas Giger and Jordi Marti will be on-site at Stand 7.

This is our first time exhibiting here, so we’re eager to learn what you’re working on. What issues or complexities would you like to improve in your cell and gene therapy R&D or manufacturing workflows? We’re here to discuss, troubleshoot, and find solutions for you. 🧬

If you register by November 7, you will save €200 Euros.
👉 Learn more: https://informaconnect.com/celltherapy/

Bis bald!

11/04/2025

Back in August, we held our first Cell Summit ‘25 meeting for cell and gene therapy development and manufacturing. This event included expert-led discussions and networking in a collaborative format with a focus on CGT solutions, best practices, innovations, and process optimization.

We’ve partnered with Genetic Engineering & Biotechnology News (GEN) to publish a Proceedings eBook of insights from the event. The eBook features contributions from our co-sponsors Azenta Life Sciences, Entegris, and part of our scientific bench - Alireza Abazari, Sean Werner, Jason Acker, and Robert Ben.

How many events provide you with follow-up of actionable insights to make meaningful improvements?

Experience the difference with The Cell Summit. Download the FREE eBook today:
https://promo.genengnews.com/biolife-cell-summit-25-proceedings/

P.S. We can’t wait to share our plans with you for the 2026 event…stay tuned!

10/30/2025

Change is constant. As the cell and gene therapy industry evolves and changes, so have we…

We’re thrilled to announce our NEW website and brand messaging!

We present to you a refreshed visual and verbal identity that is clear, unified, and designed specifically to help you navigate the complexity of cell and gene therapy development and manufacturing.

Our new tagline “Preserving the Promise™” highlights our mission to protect the integrity of cells with our trusted tools, services, and expertise to help you advance science and therapy success.

Check it out: www.biolifesolutions.com

10/28/2025

Biopreservation is central to the success of cell and gene therapy (CGT) manufacturing. Your freezing, storage and thawing processes can directly affect cell viability, downstream workflow success, and therapeutic outcomes.

In our latest blog post, we discuss how partnering with experienced and knowledgeable providers, like BioLife Solutions, can help you protect cell function, optimize processes, and ensure product quality and regulatory compliance.

Highlights:
* The importance of biopreservation
* BioLife Solutions’ scientific leadership and expertise
* Ice crystal growth control and cryoprotectant innovation

Read on: https://go.biolifesolutions.com/l/103972/2025-10-27/5xlg5t

10/23/2025

BioLife Solutions to Report Third Quarter 2025 Financial Results and Business Update on November 6, 2025

Read the press release for webcast and login information.

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the Company's third...